Bristol Myers Squibb BMY
NYSE BMY
$61.69 +2.85 (+4.85%)
As of: Oct 20, 2026 · 3:59 PM EDT

Bristol Myers Squibb (BMY) Assets (2009 - 2026)

Updated

Bristol Myers Squibb's Assets was $87.63 billion in Q2 2026, down 7.4% from $94.68 billion a year earlier but up 1.3% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Assets at Bristol Myers Squibb came in at $90.04 billion, down 2.8% from FY2024.

  • Assets has now declined for six consecutive years, with a five-year compound annual growth rate of -5.3% (FY2020 to FY2025).
  • In earlier years, Assets was $92.6 billion in FY2024 (-2.7%), $95.16 billion in FY2023 (-1.7%), $96.82 billion in FY2022 (-11.4%) and $109.31 billion in FY2021 (-7.7%).
  • Quarterly Assets has moved between $86.48 billion (Q1 2026) and $110.89 billion (Q3 2021) over five years.
  • Compared with a year earlier, Assets has declined for three straight quarters, with an average decline of 2.5% over the last eight quarters.
  • The best year-over-year quarter for Assets over five years was Q1 2024 (growth of 5.0%); the worst was Q3 2021 (a decline of 11.7%).
  • Per Business Quant data, BMY's Assets in the three quarters before Q2 2026 was $86.48 billion (Q1 2026), $90.04 billion (Q4 2025) and $96.89 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 201.06 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 135.12 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 115.83 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 49.36 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 201.13 Bn
10 Bristol Myers Squibb 126.07 Bn 77.35 Bn 9.25 Bn 87.63 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 87.63 Bn
Mar 31, 2026 86.48 Bn
Dec 31, 2025 90.04 Bn
Sep 30, 2025 96.89 Bn
Jun 30, 2025 94.68 Bn
Mar 31, 2025 92.43 Bn
Dec 31, 2024 92.60 Bn
Sep 30, 2024 93.67 Bn
Jun 30, 2024 94.65 Bn
Mar 31, 2024 99.03 Bn
Dec 31, 2023 95.16 Bn
Sep 30, 2023 91.26 Bn
Jun 30, 2023 93.49 Bn
Mar 31, 2023 94.28 Bn
Dec 31, 2022 96.82 Bn
Sep 30, 2022 98.20 Bn
Jun 30, 2022 100.36 Bn
Mar 31, 2022 103.03 Bn
Dec 31, 2021 109.31 Bn
Sep 30, 2021 110.89 Bn
API Access

Bristol Myers Squibb Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=BMY&period=max&api_key=YOUR_API_KEY